Diseases, Conditions, Syndromes
Drinking coffee may reduce the risk of liver cirrhosis
Regular consumption of coffee was linked with a reduced risk of liver cirrhosis in a review of relevant studies published before July 2015.
Feb 1, 2016
0
20
Cirrhosis
Cardiology
Paracentesis underutilized in patients with cirrhosis, ascites
(HealthDay)—For patients admitted with diagnoses of cirrhosis and ascites, paracentesis is associated with decreased in-hospital mortality but is underutilized, according to a study published online Dec. 8 in the Journal ...
Dec 11, 2015
0
0
Diseases, Conditions, Syndromes
Scientists discover a potential treatment for cirrhosis
A study by IRB Barcelona and IDIBAPS reveals a therapeutic target to prevent the development of the many abnormal blood vessels that cause gastrointestinal bleeding—the main complication in cirrhosis.
Dec 11, 2015
0
13
Diseases, Conditions, Syndromes
Low-dose rifaximin cuts endotoxin level in cirrhosis
(HealthDay)—For patients with liver cirrhosis, low-dose rifaximin is comparable to high-dose rifaximin for reducing serum endotoxin levels, according to a study published online Oct. 16 in the Journal of Digestive Diseases.
Oct 29, 2015
0
3
Genetics
Researchers find new genetic variants that put heavy drinkers at higher risk of liver cirrhosis
(Medical Xpress)—A large team of researchers affiliated with multiple institutions in several European countries has found new genetic variants that put heavy drinkers at higher risk of developing cirrhosis of the liver. ...
Diseases, Conditions, Syndromes
Complex gut microbiota analysis is unnecessary in diagnosis of cirrhosis
In a recent issue of the journal Nature, Virginia Commonwealth University School of Medicine associate professor Jasmohan S. Bajaj, M.D., provides new data to reinterpret conclusions from a July 2014 Nature journal study ...
Oct 5, 2015
0
19
Diseases, Conditions, Syndromes
Liver damage in hepatitis C patients significantly underestimated
The number of hepatitis C patients suffering from advanced liver damage may be grossly underestimated and underdiagnosed, according to a study led by researchers at Henry Ford Health System and the U.S. Centers for Disease ...
Aug 18, 2015
0
43
Diseases, Conditions, Syndromes
Technivie approved for hepatitis C
(HealthDay)—Technivie (ombitasvir, paritaprevir and ritonavir) has been approved by the U.S. Food and Drug Administration, in tandem with ribavirin, to treat hepatitis C genotype 4 infection among people without poor liver ...
Jul 25, 2015
0
13
Diseases, Conditions, Syndromes
Research addresses the burden of liver disease
Chronic liver diseases are steadily growing conditions, estimated to affect one in 10 Canadians. Most chronic liver diseases are "silent", attacking the liver for decades without symptoms until revealing themselves through ...
May 18, 2015
0
5
Diseases, Conditions, Syndromes
Sofosbuvir plus peginterferon/ribavirin demonstrates virologic response rates in G3 hep C patients
Results presented today at The International Liver Congress 2015 demonstrate that hepatitis C (HCV)-infected genotype-3 (GT-3) patients, with and without cirrhosis, receiving 24 weeks of sofosbuvir (SOF) in combination with ...
Apr 25, 2015
0
4
